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Abstract
Background: Acupuncture is considered to be an effective and safe treatment for obese and overweight patients,
although high-quality evidence regarding the effects of acupuncture on obesity are not conclusive. The aim of the
current study is to investigate the effectiveness of electro-acupuncture plus lifestyle modification for treating obese
and overweight patients, in comparison with lifestyle modification alone in China.
Methods/Design: To compare the effectiveness of acupuncture plus lifestyle modification, a 2-armed, controlled
trial with randomization using minimization will be conducted on 150 simple obesity and overweight patients,
aged 18–50 years, for a 36-week study duration. All patients will be randomly assigned to one of two groups and
will receive either acupuncture plus lifestyle modification or lifestyle modification alone. Outcomes will be evaluated
at baseline and at 4 weeks, 8 weeks, and 12 weeks during treatment as well as at 6-week, 12-week, and 24-week
follow-up. The primary endpoint is change of body mass index (BMI) during the 12th week. Secondary endpoints are
body weight; waist-to-hip ratio; biochemical tests including serum cholesterol (TC), triglyceride (TG) and high-density
lipoprotein (HDL) levels; and answers to the Short Form 36 (SF-36) and the Impact of Weight on Quality of Life
Questionnaire-Lite Version (IWQOL-Lite). Statistical analyses will be based on the intention-to-treat (ITT) principle.
The main endpoint will be analyzed by analysis of covariance (ANCOVA), and the objective outcome results will
be analyzed by logistic regression analysis. To avoid potential confounding factors, additional sensitivity analyses
will be conducted following these statistical analyses.
Discussion: This trial is the first to compare the effectiveness of acupuncture plus lifestyle modification for treating
obesity relative to lifestyle modification treatment alone by using a pragmatic study design. We hope that the results
of this study will contribute to advancing the current methodology of acupuncture trials for obesity and will facilitate
the application of useful acupuncture strategies in real-world clinical settings.
Trial registration: ChiCTR-TRC-12002762. The date of registration is 31 October 2012.
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Background
Obesity, defined as a body mass index (BMI) greater than
28 kg/m2 in China, is a serious and prominent health issue
worldwide. It contributes to multiple morbidities, includ-
ing coronary heart disease, type 2 diabetes, polycystic
ovary syndrome (PCOS), breast cancer, colon cancer, renal
cancer, and many other serious pathologies [1–4]. Cur-
rently, obesity is estimated to affect over 396 million indi-
viduals and to cause 3.4 million deaths, 3.9 % of years of
life lost, as well as 3.8 % of Disability-adjusted Life-Years
(DALYs) across the globe [5, 6]. Moreover, the prevalence
of obese and overweight adults in China has risen to
12.0 % and 30.6 %, respectively, during 2010 [7]. In re-
sponse to the sharp increase of obese and overweight indi-
viduals, numerous obesity treatments are commonly used
on these patients. However, pharmacological drugs for the
management of obesity and being overweight, including
orlistat, lorcaserin, and the combination of phentermine
and topiramate, are constantly being debated due to their
side effects, such as gastrointestinal and menstrual disor-
ders, possible liver damage, and lack of long-term safety
assurance [8–10].
Acupuncture, on the other hand, originating from China
and established on the framework of traditional Chinese
medicine (TCM), is one of the most important alternative
and complementary therapies for treating numerous dis-
eases. While acupuncture has been practiced worldwide,
the lack of high-quality clinical evidence makes acupunc-
ture a highly controversial therapy. Based on a series of
clinical studies, which showed that acupuncture at acu-
points was no more effective than acupuncture at non-
acupoints, some researchers have wondered whether the
effect of acupuncture is only due to the placebo effect or
to bias. Recently, a meta-analysis including 18,000 random-
ized patients in high-quality randomized control trials has
manifested novel evidence that acupuncture is superior to
sham acupuncture and placebo for managing chronic pain
[11]. Meanwhile, a meta-analysis containing 3013 individual
patients has also indicated that acupuncture can signifi-
cantly reduce average body weight (95 % confidence inter-
val (CI) of 1.72 kg (0.50–2.93 kg)) and improve obesity
rates (relative risk = 2.57; 95 % CI, 1.98–3.34) compared to
lifestyle modification [12]. Furthermore, the latest system-
atic review has shown that acupuncture is more effective
than placebo or lifestyle modification to reduce body weight
and has similar effects as western anti-obesity drugs but
with fewer adverse effects [13]. Thus, there is an increasing
tendency to use acupuncture as an adjunctive therapy
based on basic lifestyle modification treatment for obesity
in both western and eastern countries.
Although acupuncture’s multiple benefits have been
proved by many, convincing evidence regarding the use of
acupuncture for treating obesity is still limited due to the
low-quality methodologies and small sample sizes. Cho
et al. [12] have summarized that two thirds of acupuncture
trials on obesity, drawing from a total of 31 studies, are val-
ued as having low Jadad scores. By performing a systematic
review of acupuncture and Chinese medicine on obesity,
Sui et al. [13] have concluded that studies conducted within
China have a lower methodological quality than those out-
side of China. Sui et al. also have argued that the limitations
in Chinese trials include a lack of information on blinding,
methods of randomization, and reasons for discontinuation.
Additionally, there was little confirmatory evidence regard-
ing the types of acupuncture offered to obese patients.
Various types of acupuncture, including manual acupunc-
ture, electro-acupuncture, auricular acupuncture, auricular
acupress, electro-acupuncture plus auricular acupress, and
electro-acupuncture plus lifestyle modification, are applied
for daily clinical obesity treatment. Although electro-
acupuncture is more frequently performed in both clinical
obesity treatment and obesity experiments [12–16], so far
there is no convincing evidence supporting its effectiveness
in treating obesity. Hence, two pivotal questions relating to
electro-acupuncture for obesity treatment have been raised.
First, does electro-acupuncture plus lifestyle modification
show a better effect than conventional lifestyle treatment
for treating obese or overweight patients in a high-quality
randomized controlled trial in China? Second, is electro-
acupuncture plus lifestyle modification treatment suitable
for daily clinical obesity treatment?
To address these two questions, here we are proposing
a pragmatic study design. Pragmatic trials, such as com-
parative effectiveness trials, have been widely employed to
evaluate the effectiveness of an intervention applied for
the usual clinical conditions [17–19]. The advantage of
the pragmatic design is that it properly suits the essence
of Chinese medicine and acupuncture for its complexity
and pragmatism. With the aid of the comparative effect-
iveness trial design, acupuncturists can perform different
treatments and determine personalized acupoints by
themselves in acupuncture trials [20–22]; this offers flexi-
bility for both acupuncturists and patients, with the bene-
fit of the clinical effects of acupuncture according to TCM
doctrine. Hugh et al. [23] have recently performed a com-
parative effectiveness trial to compare the effectiveness of
acupuncture and counseling for treating depression. This
research set a successful example for the use of pragmatic
trials in clinical acupuncture studies.
Herein, we designed a comparative effectiveness trial
to evaluate the effectiveness of electro-acupuncture plus
lifestyle modification treatment for simple obesity and
overweight patients.
Aims
The main objective of this study is to investigate the ef-
fectiveness of electro-acupuncture plus lifestyle modifica-
tion treatment for simple obesity and overweight patients
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(assessed by BMI and body weight) in comparison with
lifestyle modification treatment alone.
Methods
Study design
A randomized, controlled, 2-armed trial using a parallel
design with a 36-week study duration for each patient
will be conducted to test 2 different hypotheses:
H0: acupuncture plus lifestyle modification = lifestyle
modification (null hypothesis) versus H1: acupuncture
plus lifestyle modification ≠ lifestyle modification (alter-
native hypothesis).
To test these hypotheses, patients will be randomized
into one of two groups as shown in Fig. 1.
Patients
To be included in this study, patients need to fulfill the
following criteria: be male or female, aged 18–50 years
old, and have a BMI ≥ 24 kg/m2, as diagnosed by their
general physician in accordance with the guidelines of
prevention and treatment for overweight and obesity in
Chinese adults [24]. The patients should have failed pre-
viously to achieve their weight-loss goals through diet
and exercise alone, and be willing to accept acupuncture
and lifestyle modification after the explanation of risks
and benefits regarding these two therapies. In addition,
the ability to read and understand consent forms and
questionnaires is required.
Patients will be excluded if they meet the following
criteria: they have inherited obesity or secondary obes-
ity; an endocrine disease such as a thyroid disorder, pi-
tuitary disorder, or sex gland disorder; heart disease
such as arrhythmia, heart failure, myocardial infarction,
or require a pacemaker; allergic or immune disease;
kidney disease such as diabetic nephropathy, secondary
focal segmental glomerulosclerosis, high amino trans-
ferases (alanine, aspartate > 50 U/L), or high serum cre-
atinine (4.25 mg/dL); or are a pregnant or lactating
woman. In addition, patients who have managed their
weight for 1 month or have any other conditions un-
suitable for this trial as evaluated by a general physician
will be excluded.
Fig. 1 Flow chart of study
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All patients will be recruited in outpatient clinics of
the Affiliated Hospital of Nanjing University of Chinese
Medicine. Additional advertisements will be conducted
in five universities in Nanjing, China. The Handbook of
Obesity will also be printed and sent to all patients.
Minimization randomization and blinding
Minimization randomization scheme will be performed at
the Nanjing Good Clinical Practice (GCP) center through
three different steps according to the extending Consoli-
dated Standards of Reporting Trials (CONSORT) state-
ment of Revised Standards for Reporting Interventions in
Clinical Trials of Acupuncture (STRICTA) [25]: sequence
generation, allocation concealment, and implementation.
Sequence generation
Patients will be randomly allocated to one of two groups in
a 1:1 ratio using a minimization procedure controlled by
the GCP center. Minimization is used to balance the sever-
ity of obesity, age, and gender between the two groups. The
severity of obesity is divided into 4 levels, including over-
weight (24 ≤ BMI < 28), obesity I (28 ≤BMI ≤ 32), obesity II
(32 < BMI < 35), and obesity III (BMI ≥ 35) [26–29]. Once
the severity of obesity, age, and gender of the patients are
inputted in the online software, the minimization proced-
ure will be implemented by a skilled statistician.
Allocation concealment
An Email or short message service message (SMS) de-
tailing the random numbers and group assignment will
be sent directly to the study assistant from the GCP cen-
ter. Acupuncturists in this trial will not recruit patients,
and the group assignment cannot be changed once it
has been made.
Implementation
All patients who meet the inclusion criteria will be en-
rolled by one of two independent recruiters from the
outpatient clinics of the study hospital and universities.
After inclusion, a study assistant will send the patient’s
information, including name, gender, numerical birthday,
and BMI index, to the GCP center. A random allocation
sequence will be generated by the GCP center computer
when it receives the minimization information. Finally,
the GCP center computer will send the random num-
bers and the group assignment back to the study assist-
ant by Email or SMS.
Blinding
The acupuncturists and nutritionists will not be blinded
due to the pragmatic trial design. The statistician will re-
main blinded from the identity of the two treatment
groups until the end of the study.
Intervention
Electro-acupuncture plus lifestyle modification group
The acupuncture prescription
The acupuncture prescription was selected by three
steps: first, literature articles and systematic reviews re-
garding ancient acupuncture treatment for obesity were
collected [12, 13, 30–32]; the frequency of acupoints for
obesity was analyzed. The stomach, spleen, Ren merid-
ian, ST36, ST40, ST25, SP6, CV12, CV4, and CV6 are
most frequently used in obesity treatment. Subsequently,
the further acupuncture protocol was discussed and de-
veloped with experts from multiple disciplines, including
professional acupuncture experts, acupuncturists, nutri-
tionists, physicians, and statisticians. LI11, LI4, CV12,
ST25, CV4, ST36, SP6, and ST44 were finally selected
for use based on the literature, clinical experience, and
TCM doctrine.
Specifically, semi-standard acupuncture treatment will
be applied in this study. The acupuncturist who per-
forms acupuncture on patients can choose additional
acupoints beyond this main acupuncture prescription
according to their TCM diagnoses and experiences. In
addition, standard operating procedures (SOPs) of acu-
puncture will be constructed according to the Revised
STRICTA guidelines [25].
Application of electro-acupuncture
Patients allocated to the acupuncture plus lifestyle group
will receive electro-acupuncture treatment as follows: a
total of 7 sterile disposable stainless steel needles (diameter:
0.25 mm; length: 40 mm, Hwatuo, Suzhou, China) will be
punctured unilaterally at a depth of 25–35 mm in LI11,
LI4, CV12, CV4, ST36, SP6, and ST44 on the patients, and
performed alternately at the next treatment. Another 2
sterile disposable stainless steel needles will be punctured
bilaterally at a depth of 25–35 mm in ST25 on the patients.
Acupuncture manipulation will be used to achieve the Deqi
sensation. Transcutaneous electro-acupuncture stimulation
will be then conducted at acupoints for 30 minutes using a
Han’s acupoint nerve stimulator (HANS-200, Nanjing,
China). The stimulation frequency will be set at 2/15 Hz,
and the intensity will vary from 0.1 mA to a maximum of
2.0 mA until the needle handle begins to tremble slightly.
Acupuncture treatment will be performed 3 times per
week according to the patient’s convenience, and a total of
36 acupuncture treatments will be performed on the pa-
tients in the acupuncture plus lifestyle modification group.
All the acupuncturists in this trial are qualified TCM doc-
tors. They have at least 8 years of acupuncture training
experience and have a Master's degree in acupuncture.
In addition, patients allocate to the electro-acupuncture
plus lifestyle modification group will also receive lifestyle
modification treatment combined with electro-acupuncture
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treatment. The lifestyle modification treatment will be iden-
tical to that used for the lifestyle modification group below.
Lifestyle modification group
The lifestyle modification treatment was designed by ex-
perienced nutritionists, and the treatment protocol was
established before the study began. Firstly, each patient’s
lifestyle, including daily nutrient intake and exercise habit,
will be collected using a dietary questionnaire [33, 34] and
analyzed by a nutritionist at the beginning of the study. A
face-to-face nutritional consultation will be subsequently
arranged for each patient, in order to tailor an individual-
ized lifestyle treatment. The possible goal of weight reduc-
tion for each patient will be set at this face-to-face
nutritional consultation. Accordingly, a 24-hour food re-
call diary will be used to record mean nutrient intake dur-
ing 24 hours for all the patients [35–37]. Three days of
food recall diaries during each week will be collected from
each patient within 3 months, for the purpose of estimat-
ing nutrition intake and self-monitoring dietary food in-
take. Individualized nutrition and activity advice will be
given to each patient in terms of their weight-loss goals
and food diaries during each week. In detail, according to
Dietary Guidelines for Chinese Residents [38], it will be
suggested that overweight and obese patients reduce at
least 300–500 kcal of their daily nutrition intake, as well
as increase by 8000–10,000 steps their daily activities dur-
ing treatments. Finally, a total of 12 nutritional consulta-
tions will be given to all the patients enrolled into study
within the 12-week treatment period. Specifically, social
network software (QQ, WeChat) will be used to establish
a social network among all the patients, promoting the
persistence of treatment.
Outcomes
The primary outcome is the change of BMI during the
12th week after minimization. The formula for BMI is as
follows:
BMI =mass (kg)/(height(m))2.
The BMI of all patients will be calculated at baseline;
during treatment at 4, 8, and 12 weeks; and 6-week, 12-
week, and 24-week follow-up [39]. The BMI reduction
will be assessed by a blinded investigator from the Clinic
of Nanjing University of Chinese Medicine.
The secondary outcomes are divided into objective out-
comes and patient-centered outcomes. The body weight
and the waist-to-hip ratio will be used as supplementary
measures in combination with the BMI, and will be calcu-
lated at baseline; during treatment at 4, 8, and 12 weeks;
and at 6-week, 12-week, and 24-week follow-up. In
addition, TC, TG, and HDL levels also will be tested at
baseline; during treatment at 4, 8, and 12 weeks to assess
the metabolic changes [40]. For patient-centered outcomes,
IWQOL-Lite and SF-36 are used to measure obesity-
specific quality of life. The IWQOL-Lite questionnaire is a
validated, obesity-specific measure, consisting of 31 items
regarding the impact of obesity on physical function, self-
esteem, sexual life, public distress, and work [41–43]. Pa-
tients will be asked to rank items related to obesity in 5
areas, ranging from 5 “always true” to 1 “never true”, by
an independent assessor. The independent assessor will
give a detailed explanation regarding every item of this
questionnaire to patients before the treatment. All the
patient-centered outcomes will be detected before treat-
ment; during treatment at 4, 8, and 12 weeks; and at 6-
week, 12-week, 24-week follow-up. Adverse events and
serious adverse events will be recorded during the study
to assess safety. By using a valid expectation questionnaire
relating to acupuncture [44], participants’ expectations for
acupuncture at baseline will also be assessed.
Statistics
Sample size calculation
The sample size was determined prospectively as de-
scribed in a previous study that used similar outcome
measurements [45]. The following formula was used to
estimate the sample size:




An independent statistician will monitor the study de-
sign from the beginning of the study and take responsi-
bility for calculating the sample size and all data.
Acupuncture treatment is reported to cause a 4.84 ± 7.38
(mean ± standard deviation) kg reduction of body weight
compared to lifestyle modification treatment alone, ac-
cording to a previously published systematic review [12].
This study was designed to have 80 % power and a sig-
nificance level of 5 % for the purpose of discriminating
differences between electro-acupuncture plus lifestyle
modification and lifestyle modification alone. To achieve
this, 64 patients will be included in each group and a
total number of 150 patients will be enrolled, allowing
for a 15 % dropout rate per group.
Analysis
The primary outcome is the change of BMI during the
12th week after minimization. To determine differences
between the 2 groups after 12 weeks, analysis of covari-
ance (ANCOVA) will be used to adjust for baseline
values. Because there are two primary analyses (electro-
acupuncture plus lifestyle modification versus lifestyle
modification alone), Bonferroni correction will be used
to address multiple testing, and a significance level of
0.05 will be used.
Statistical analyses of primary and secondary outcomes
will be conducted as follows. First, all the analyses will
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be based on the intention-to-treat (ITT) principle. All pa-
tients, who will provide baseline data, will be included in
the analyses, regardless of whether or not they complete
the treatment or adhere to the protocol. Data distribution
is expected to be normal, and skewed distribution data
will be transformed prior to analysis. The statistical hy-
potheses are:
H0: acupuncture plus lifestyle modification = lifestyle
modification (null hypothesis) versus H1: acupuncture
plus lifestyle modification ≠ lifestyle modification (alter-
native hypothesis).
ANCOVA will be subsequently performed on BMI,
body weight, and waist-to-hip ratio data as well as SF-36
and IWQOL-Lite. SF-36 and IWQOL-Lite will be trans-
formed to continuous variables before analysis. Missing
values will be addressed using the methods of last obser-
vation carried forward (LOCF). To address the results of
objective outcomes, logistic regression analysis will be
used to analyze dependent variables, including TC, HDL,
and TG levels. These statistical analyses will be performed
using SPSS 15.0 statistics software (SPSS Inc., Chicago, IL,
USA) and SAS 9.0 (SAS Institute Inc., Cary, NC, USA).
To avoid potential confounding factors, additional sen-
sitivity analyses will be conducted following these statis-
tical analyses by using STATA (StataCorp, College
Station, TX, USA) or R methods. Patient expectations
also will be included as ordinal fixed factors in the sensi-
tivity analyses. Full analysis set and the potential con-
founding factors relating to baseline differences will be
used to calculate the results.
Safety monitoring
Routine tests, including blood, urine, and stool sample ana-
lyses, electrocardiogram, and abdominal B ultrasound, will
be performed on all patients before minimization. These
test results will be part of the inclusion and exclusion evi-
dence screened by a general physician. Acupuncture ad-
verse events are defined as bleeding, fainting, hematoma,
serious pain, and local infection. All adverse events, as well
as managing these events, will be carefully recorded during
the treatment and in the follow-up phases.
Quality control
A diverse study group including the principal investiga-
tor, recruiters, acupuncturists, nutritionists, data man-
ager, monitor, and patients will be established before the
study. All of them contribute to the design of this study.
Basic study training to understand the design, purpose,
and basic information will be performed before the
study. In addition, an independent data manager will be
responsible for saving and managing the various data. A
checklist including all the important aspects during the
study will be made, and a trained monitor will check this
checklist and report the quality assurance throughout
the trial in accordance with the protocol. Acupuncturists
and nutritionists will be free to conduct individualized
treatment for each patient due to the pragmatic trial de-
sign. Therefore, a few procedures will be undertaken to
inspect their treatment. Patient withdrawal and adverse
events during the study will be recorded in detail. Regu-
lar team meetings will be held and fully documented.
Regulatory and ethics approval
This study was approved by the Chinese Ethics Commit-
tee of Registering Clinical Trials (ChiECRCT-2012012)
and is in compliance with the common guidelines for clin-
ical trials (Helsinki Declaration). The registration number
of this trial is ChiCTR-TRC-12002762. All recruited pa-
tients will obtain and sign an informed consent form.
Resource
This study is supported by grants from the National Nat-
ural Science Foundation of China (number 81202741,
number. 81273838) and the Research Fund for the Doc-
toral Program of Higher Education of China (number
20123237120009).
Discussion
For the first time, this study will evaluate the effectiveness
of a combined intervention including both acupuncture
and lifestyle modification for treating obesity in compari-
son with lifestyle modification alone in a normal clinical
setting. The aim of this study is to conduct a pragmatic
trial which not only will improve the methodology of acu-
puncture trials on obesity in China but also develop bene-
ficial acupuncture strategies for obesity treatment favoring
real-life practical settings. This protocol is in accordance
with the STRICTA [22], the Effectiveness Guidance Docu-
ment (EGD) for acupuncture research [46] and the exten-
sion of the CONSORT statement for reporting pragmatic
trials [18]. The checklist for Comparative Effectiveness Re-
search (CER) relevant aspects for acupuncture clinical
studies has been checked before the study begins.
The main challenge of this trial is to innovate a prag-
matic study protocol uniting personalized acupuncture
treatment with advanced research methodologies. To re-
solve this challenge, a dimensional study group, including a
renowned acupuncture professor, skilled acupuncturists,
nutritionists, clinical methodologists, physicians, and pa-
tients, was built before the study began. Each aspect of the
study design was fully discussed and revised by this group.
Since the populations of obese and overweight adults in
China have climbed to 12.0 % and 30.6 %, respectively,
both obese and overweight patients will be enrolled in this
study, reflecting those who usually receive treatment for
weight-loss in terms of a pragmatic design. Lifestyle modi-
fication is the cornerstone among all the obesity treatments
currently available. We therefore employ acupuncture plus
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lifestyle modification as an intervention in this trial, facili-
tating the real-world clinical treatment of obesity. To
evaluate patient-reported outcomes, the IWQOL-Lite
questionnaire will measure the impact of obesity on di-
mensional aspects of life. This questionnaire has been
made by researchers at Duke University and has been used
successfully in many obesity trials [47–50]. To monitor the
food intake of overweight and obese patients, a 24-hour
food recall diary will be applied to record mean nutrient
intake during 24 hours. This diary is a valid instrument for
estimating nutrition intake and a beneficial tool for self-
monitoring of dietary intake. It has been proved and
performed in numerous nutrition researches [32–34].
Moreover, minimization will be conducted as a random
procedure in this trial, avoiding possible confounding fac-
tors such as different obesity levels, gender, and age. Add-
itionally, an Internet social network will be established and
be used throughout the study, promoting the persistence
of treatment for patients during treatment and follow-up
phases.
As this trial refers to two clearly different treatments,
blinding is hard to perform after minimization. Hence, a
limitation of internal validity and multiple potential
biases, including expectations of the patients and pro-
viders, may occur during this study. To minimize these
potential biases, most of the outcomes in this trial are
designed to be objective outcomes, such as BMI, body
weight, waist-to-hip ratio, and biochemical tests.
In summary, this is a pragmatic study design with a
focus on the effectiveness of acupuncture plus lifestyle
modification for treating obesity. It is our hope that this
study is a useful attempt to advance the methodology of
acupuncture trials, and the results may disclosure novel
evidence for the effectiveness of acupuncture on obesity.
Trial status
This study is recruiting patients.
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